Evidence map›Paper›PMID 25417112›Full record

ArticleCell2014

Target-selective protein S-nitrosylation by sequence motif recognition.

Jie Jia, Abul Arif, Fulvia Terenzi, Belinda Willard, Edward F Plow, Stanley L Hazen, Paul L Fox

Open access · greenAbstract read
In one paragraph

Article in Cell, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 171 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. FromActa pharmaceutica Sinica. B · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Identification of Protein Targets ofACS chemical biology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jie JiaDepartment of Cellular and Molecular Medicine, The Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Abul ArifDepartment of Cellular and Molecular Medicine, The Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Fulvia TerenziDepartment of Cellular and Molecular Medicine, The Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Belinda WillardMass Spectrometry Laboratory for Protein Sequencing, The Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Edward F PlowDepartment of Molecular Cardiology, The Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Stanley L HazenDepartment of Cellular and Molecular Medicine, The Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Paul L FoxDepartment of Cellular and Molecular Medicine, The Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: foxp@ccf.org.
Cleveland Clinic Lerner College of Medicine · US

Funding

Clinical and Translational Science Collaborative of ClevelandUL1TR000439 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$50.0M
Vascular Cell function and AtherosclerosisP01HL029582 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI FOX, PAUL L · 1985 to 2019
$32.0M
Structural Determinants Of Ceruloplasmin Inflammatory ActivityP01HL076491 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI PLOW, EDWARD FRANKLIN · 2004 to 2019
$27.3M
THE CLASSICAL AND ALTERNATIVE PATHWAYS OF FIBRINOLYSISR01HL017964 · NHLBI · SCRIPPS RESEARCH INSTITUTE · PI PLOW, EDWARD FRANKLIN · 1985 to 2015
$5.6M
A protein-directed RNA switch that regulates translationR01GM086430 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI FOX, PAUL L · 2009 to 2016
$2.6M
LTQ-Orbitrap Velos instrumentS10RR031537 · NCRR · CLEVELAND CLINIC LERNER COM-CWRU · PI WILLARD, BELINDA BELLE · 2011 to 2011
$600k
NCATS NIH HHS UL1 TR000439NCRR NIH HHS S10 RR031537NHLBI NIH HHS P01 HL029582NHLBI NIH HHS P01 HL076491NHLBI NIH HHS R01 HL017964NIGMS NIH HHS R01 GM086430
6 · The paper itself

Abstract

S-nitrosylation is a ubiquitous protein modification emerging as a principal mechanism of nitric oxide (NO)-mediated signal transduction and cell function. S-nitrosylases can use NO synthase (NOS)-derived NO to modify selected cysteines in target proteins. Despite proteomic identification of over a thousand S-nitrosylated proteins, few S-nitrosylases have been identified. Moreover, mechanisms underlying site-selective S-nitrosylation and the potential role of specific sequence motifs remain largely unknown. Here, we describe a stimulus-inducible, heterotrimeric S-nitrosylase complex consisting of inducible NOS (iNOS), S100A8, and S100A9. S100A9 exhibits transnitrosylase activity, shuttling NO from iNOS to the target protein, whereas S100A8 and S100A9 coordinately direct site selection. A family of proteins S-nitrosylated by iNOS-S100A8/A9 were revealed by proteomic analysis. A conserved I/L-X-C-X2-D/E motif was necessary and sufficient for iNOS-S100A8/A9-mediated S-nitrosylation. These results reveal an elusive parallel between protein S-nitrosylation and phosphorylation, namely, stimulus-dependent posttranslational modification of selected targets by primary sequence motif recognition.

Indexed as

Protein Processing, Post-TranslationalAmino Acid MotifsAmino Acid SequenceAnimalsCalgranulin ACalgranulin BGlyceraldehyde-3-Phosphate DehydrogenasesHumansInterferon-gammaLipoproteins, LDLMiceModels, MolecularMolecular Sequence DataMultiprotein ComplexesNitric OxideNitric Oxide Synthase Type IICalgranulin ACalgranulin BGlyceraldehyde-3-Phosphate DehydrogenasesInterferon-gammaLipoproteins, LDLMultiprotein ComplexesNitric OxideNitric Oxide Synthase Type IIProteins

Identifiers

PMID25417112
PMCPMC4243042
OpenAlexW2023216398

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.